Skip to content

Released Aug 5, 2015, after the close

10-Q filed Aug 5, 2015, 36 days after period end · 0001104659-15-056485

Q2 2015 · 10-Q
Revenue$329.00Kno prior Q2 2014 on fileno prior Q1 2015 on file
Net Income-$7.78MN/M vs Q2 2014N/M vs Q1 2015
EPS Diluted-$0.33N/M vs Q2 2014N/M vs Q1 2015
Operating Income-$7,218,000N/M
Operating Cash Flowderived$2,079,000N/M
Free Cash Flowderived$1,866,000N/M
Margins · derived
Operating margin-2193.9%
Net margin-2364.4%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2015Q2 2014Q2 2013Q2 2012
Revenue$329.00K—$290.00K$1.08M
Net Income-$7.78M-$6.07M-$5.53M-$2.74M
EPS Diluted-$0.33-$0.30-$4.46-$2.58

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Fate Therapeutics Inc · CIK 1434316 · Engraved from SEC EDGAR